|
|
|
|
|
|
|
|
|
| Revenue from sale of goods* |
748 477 |
|
– |
|
– |
|
– |
|
| Administration fees |
1 230 288 |
|
1 163 579 |
|
– |
|
– |
|
| Health risk management fees |
805 104 |
|
703 370 |
|
– |
|
– |
|
| Management fees |
1 222 |
|
4 350 |
|
– |
|
– |
|
| IT revenue and other |
363 055 |
|
227 013 |
|
50 |
|
– |
|
| Revenue from performance of services |
2 399 669 |
|
2 098 312 |
|
50 |
|
|
|
| Total revenue |
3 148 146 |
|
2 098 312 |
|
50 |
|
– |
|
* This relates to sale of pharmaceutical products which resulted from the WAD
acquisition effective 1 August 2015.
|